Vimarsana
Biggest News Aggregation in the World

Nephrology Task Force News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nephrology Task Force. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nephrology Task Force Today - Breaking & Trending Today

Sudan: Clashes between SAF and RSF - Flash Update No. 15 (6 June 2023) - Sudan - Vimarsana News

Sudan: Clashes between SAF and RSF - Flash Update No. 15 (6 June 2023) - Sudan

Situation Report in English on Sudan and 5 other countries about Contributions, Education and more; published on 7 Jun 2023 by OCHA

Sudan: Clashes between SAF and RSF - Flash Update No. 15 (6 June 2023) [EN/AR] - Sudan - Vimarsana News

Sudan: Clashes between SAF and RSF - Flash Update No. 15 (6 June 2023) [EN/AR] - Sudan

Situation Report in Arabic on Sudan and 5 other countries about Contributions, Education and more; published on 7 Jun 2023 by OCHA

New European Cystatin C Equation for eGFR May Be More Accurate - Vimarsana News

New European Cystatin C Equation for eGFR May Be More Accurate

The race-free European cystatin C equation is an effort toward accurate kidney function estimation, which is crucial for CKD management.

Serum Cystatin C for Estimation of GFR - Vimarsana News

Serum Cystatin C for Estimation of GFR

An 80-year-old man with type 2 diabetes and hypertension was referred to the nephrology clinic for persistent hyperkalemia. The patient was frail and sedentary,

ADA Updates on Finerenone, SGLT2 Inhibitors, and Race-Based eGFR - Vimarsana News

ADA Updates on Finerenone, SGLT2 Inhibitors, and Race-Based eGFR

ADA has made an interim change to its latest Standards of Medical Care, an update based on trial evidence and consensus about finerenone, SGLT2 inhibitors, and eGFR.